COVID-19:SARS-CoV-2变种的概述 - 目前的疫苗和药物开发
Narjess Bostanghadiri1, Pardis Ziaeefar2, Morvarid Golrokh Mofrad3
1Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
BioMed research international
|September 7, 2023
概括
随着COVID-19大流行的继续,新的变种对疫苗和治疗提出了挑战. 本综述涵盖了当前治疗药物和针对SARS-CoV-2的候选疫苗,以及与变种相关的问题.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 由SARS-CoV-2引起的COVID-19大流行,构成了全球卫生危机.
- 新出现的变种 (例如,B.1.1.7,B.1.351) 增加了传播能力,降低了疫苗/治疗的有效性.
- 尽管疫苗正在开发,但预防措施仍然至关重要.
研究的目的:
- 审查目前针对COVID-19的治疗药物选择.
- 讨论针对SARS-CoV-2的候选疫苗.
- 分析病毒变异对干预措施所带来的挑战.
主要方法:
- 关于COVID-19治疗方法和疫苗的最新发现的文献综述.
- 对有关SARS-CoV-2变种的科学数据的分析.
- 综合有关治疗和预防策略的信息.
主要成果:
- 几种疫苗 (例如,Pfizer/BioNTech,Moderna) 已获得批准,其他疫苗正在临床试验中.
- 各种候选药物正在进行治疗用途的研究.
- 变种对现有和正在开发的干预措施的有效性构成重大挑战.
结论:
- 对新型疗法和疫苗的持续研究至关重要.
- 应对SARS-CoV-2变种带来的挑战对于疫情控制至关重要.
- 治疗和预防策略的结合是管理COVID-19的必要条件.
更多相关视频
相关概念视频
Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Microorganisms in Medicine and Therapeutics
53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53
Viral Mutations
32.4K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.4K
Conjugated Proteins
18.4K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.4K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K


